Cryopreservation of the bone marrow from patients with acute myeloid leukaemia leads to functional abnormalities

European Journal of Haematology

Volumn 62, Issue 2, 1999, Pages 83-89

  Novitzky, Nicolas ^b   Kruger, William ^a   Mohamed, Rygana ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Bone marrow; Cryopreservation; Stroma

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CYTARABINE; DAUNORUBICIN DERIVATIVE; ETOPOSIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; STROMA CELL;

EID: 2042436734     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1999.tb01726.x     Document Type: Article

References (25)

1. NOVITZKY N, MOHAMED R. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation. Exp Hematol 1995;23:1661-1666.
2. BENNETT JM, CATOVSKY D, DANIEL MT, et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976;33:451-458.
3. NOVITZKY N, THOMAS V. Myeloablative therapy and autologous (ABMT) or allogeneic marrow transplantation (BMT) are equivalent post-remission therapy in acute myelogenous leukemia (AML). Blood 1995;86(suppl 1):386(abstr).
4. JACOBS P, WOOD L, HORAK S. Collection and cryopreservation of human stem and progenitor cells for bone marrow transplantation. J Clin Apheresis 1991;6:54-58.
5. CASTRO-MALASPINA H, GAY RE, RESNICK G, et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980;56:289-301.
6. WALDMANN H, POLLIAK A, HALE G, et al. Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1). Lancet 1984;ii:483-486.
7. UGELSTAD J, ELLIGSEN T, BERGE A. Magnetic polymer particles for cell separation. Bone Marrow Transplant 1987;2(suppl 2):74.
8. RASMUSSEN AM, SMELAND EB, ERIKSTEIN BK, et al. A new method for detachment of Dynabeads from positively selected B lymphocytes. J Immunol Methods 1992;146:195-202.
9. GORDON MY, DOWDING CR, RILEY GP, GREAVES MF. Characterisation of stroma-dependent blast colony-forming cells in human marrow. J Cell Physiol 1987;130:150-156.
10. BARNSTABLE CJ, BODMER WF, BROWN G, et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens - new tools for genetic analysis. Cell 1987;14:9-20.
11. NOVITZKY N, MOHAMMED R. Alterations in the progenitor cell population follow recovery, from myelablative therapy and bone marrow transplantation. Exp Hematol 1997;25:471-477.
12. MCFARLAND W, GRANVILLE NB, DAMESHEK W. Autologous bone marrow infusion as an adjunct in therapy of malignant disease. Blood 1959;14:503-521.
13. APPELBAUM FR, ZIEGLER JL, LEVINE AS, DEISSEROTH AB. Bone marrow autografts accelerate hemopoietic recovery following high-dose chemotherapy. Clin Res 1975;25:473A.
14. VISANI G, DINOTA A, TOSI P, et al. Cryopreserved autologous bone marrow transplantation in patients with acute nonlymphoid leukemia: chemotherapy before harvesting is the main factor in delaying hematological recovery. Cryobiology 1990;27:103-106.
15. CANALS C, MARTI JM, MARTINEZ E, et al. Hematological recovery after autologous bone marrow transplantation in acute leukemia. Prognostic factors In: DICKE KA, ARMITAGE JO, DICKE-EVINGER MJ, eds. Autologous marrow transplantation. Proceedings of the 5th International Symposium, 1990:123-134.
16. CHANG J, GEARY CG, TESTA NG. Long-term bone marrow damage after chemotherapy for acute myeloid leukaemia does not improve with time. Br J Haematol 1990;75:68-72.
17. NICOL A, NIEDA M, DONALDSON C, et al. Cryopreserved human bone marrow stroma is fully functional in vitro. Br J Haematol 1996;94:258-265.
18. ALLIERI MA, LOPEZ M, DOUAY L, MARY JY, NGUYEN L, GORIN NC. Clonogenic leukemic progenitor cells in acute myelocytic leukemia are highly sensitive to cryopreservation: possible purging effect for autologous bone marrow transplantation. Bone Marrow Transplant 1991;7:101-105.
19. KALLA P, OSTER W, SEILER FR, RUDE E, KRUMWIEH D. Myelosuppressive effects of cytosine arabinoside (Ara-C) on growth factor-dependent human long-term bone marrow cultures (LTBMC). Int J Cell Cloning 1992;10:54-62.
20. KUSHNER BR, KWON JH, GULATI SC, CASTRO-MALASPINA H. Preclinical assessment of purging with VP-16-213:key role for long-term marrow cultures. Blood 1987;69:65-71.
21. DEXTER TM, MOORE MA. In vitro duplication and "cure" of hemopoietic defects in genetically anaemic mice. Nature 1977;269:412-414.
22. ZAHEER HA, GIBSON FM, BAGNARA M, GORDON SMITH EC, RUTHERFORD TR. Differential sensitivity to cryopreservation of clonogenic progenitor cells and stromal precursors from leukemic and normal bone marrow. Stem Cells 1994;12:180-186.
23. RAO SGA, DUTTA A, BORGES M, DESAI SS, NADKARNI KS. Damage to the hemopoietic microenvironment by leukemic cells can be a limiting factor for successful bone-marrow transplantation. Hematol Rev 1993;7:21-27.
24. KOBARI L, WEIL D, LAMOINE FM, et al. Secretion of tumour necrosis factor-alpha by fresh human acute nonlymphoblastic leukemic cells: role in the disappearance of normal CFU-GM progenitors. Exp Hematol 1990;18:1187-1192.
25. MAYANI H, GUILBERT LJ, CLARK SC, BELCH AR, JANOWSKA-WIECZOREK A. Composition and functional intergrity of the in vitro hemopoietic microenvironment in acute myelogenous leukemia: effect of macrophage colony-stimulating factor. Exp Hematol 1992;20:1077-1084.